Irritable Bowel Syndrome with Diarrhea (IBS-D): Effects of Clostridium butyricum CBM588 Probiotic on Gastrointestinal Symptoms, Quality of Life, and Gut Microbiota in a Prospective Real-Life Interventional StudyFrancesco Di Pierro, Nicola Zerbinati, Fabrizio Ficuccilli et al.|Microorganisms|2025Cited by 8
The Anti-Constipation Effect of Bifidobacterium Longum W11 Is Likely Due to a Key Genetic Factor Governing Arabinan UtilizationFrancesco Di Pierro, Sara Soldi, Chiara Maria Palazzi et al.|Microorganisms|2024Cited by 5
The Role of Targeted Microbiota Therapy in the Prevention and Management of Puerperal MastitisMariarosaria Matera, Ilaria Cavecchia, Chiara Maria Palazzi et al.|Diseases|2025Cited by 4
Effect of orally administered L. crispatus M247 in favoring HR-HPV clearance and CST shift: results from a randomized, multi-center, placebo-controlled trialFrancesco Di Pierro, E Lomeo, Emanuela Giorgia Sampugnaro et al.|Scientific Reports|2025Cited by 4
E. coli 5C: a probiotic effective for preventing post-colonoscopy gastrointestinal discomfort?Francesco Di Pierro, Nicola Zerbinati, Massimiliano Cazzaniga et al.|Minerva Gastroenterology|2024Cited by 3